That's only for the P2a trial. The P2b has 75 patients.
A welcome announcement, but there is still a long way to go here. Unless we see some surprises with the other programs there will be long periods of time without much news flow imo, which means the share price will still languish. Wonder when the next CR will happen.
- Forums
- ASX - By Stock
- PTX
- Ann: US FDA allows PTX-100 Ph2 trial
PTX
prescient therapeutics limited
Add to My Watchlist
2.22%
!
4.6¢

Ann: US FDA allows PTX-100 Ph2 trial, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $37.04M |
Open | High | Low | Value | Volume |
4.5¢ | 4.9¢ | 4.5¢ | $52.77K | 1.123M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 382223 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 199999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 255557 | 0.045 |
5 | 191726 | 0.044 |
2 | 212500 | 0.043 |
3 | 509476 | 0.042 |
5 | 347317 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 90624 | 2 |
0.048 | 88000 | 1 |
0.049 | 426483 | 2 |
0.051 | 200000 | 1 |
0.053 | 148000 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online